{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-012182","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2026-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.778200+00:00","generated_at":"2026-05-15T06:29:43.643943+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ImmuCell appoints two new independent directors; three directors retire effective April 15, 2026","bullets":["Bryan Gathagan, Michael Brigham, and Bobbi Jo Brockmann retire from board effective April 15, 2026.","Gilles Guillemette DVM and Anthony DiMarco Ph.D. elected as new directors effective same date.","Board moves to 7 members with 6 independent directors; CEO remains only non-independent.","New Strategy & Technology Committee formed; Guillemette chairs it; DiMarco serves on it.","Guillemette has 30+ years animal health executive experience; DiMarco 40 years biologics R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012182","json":"https://secwatch.observer/filing/0001437749-26-012182.json","markdown":"https://secwatch.observer/filing/0001437749-26-012182.md","text":"https://secwatch.observer/filing/0001437749-26-012182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000143774926012182/0001437749-26-012182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000143774926012182/iccc20260413_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:29:43.643943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}